Saturday 17 October 2026
Export ARTL’s income statement to Excel — free account
Artelo Biosciences, Inc.
ARTL Healthcare Biotechnology
In the quarter to June 2026, EPS grew 94.7% and free cash flow fell 879.2%, each against the same quarter a year earlier.
2.70
0.04
−1.46%
Follow ARTL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
0.38 | 0.17 | 1.79 | 3.00 |
Net Debt/EBITDA |
0.57 | 0.22 | 3.95 | 1.69 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.12 | 0.70 | 0.40 | 2.07 | |
Capex/Depreciation |
(3.01) | 2.65 | 0.00 | 0.00 | |
Interest Coverage |
(27.83) | (29.64) | (21.69) | (417.50) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.55 | 0.73 | 0.16 | 0.32 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(128.80) | (71.47) | (14.51) | (16.70) | |
Cash per Share |
59.11 | 15.75 | 125.13 | 13.93 | |
Shareholders Equity per Share |
(21.75) | (33.39) | 81.27 | 16.58 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(21.75) | (33.39) | 81.27 | 16.58 | |
Free Cash Flow |
(3.75) | (2.72) | (1.19) | (5.03) | |
Working Capital |
(3.03) | (3.35) | 4.59 | 2.92 | |
Capital Expenditures |
(0.25) | 0.19 | — | — | |
Net Current Asset Value |
(3.07) | (3.38) | 4.58 | 2.91 | |
| Other line items | |||||
Quick Ratio |
0.35 | 0.15 | 1.76 | 2.89 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(120.21) | (76.40) | (14.51) | (16.70) | |
Capex per Share |
(8.59) | 4.93 | 0.00 | 0.00 | |
Average Payables |
2.25 | 2.36 | 3.28 | 3.07 | |
Average Assets |
5.70 | 3.75 | 8.02 | 5.41 | |
Average Common Equity |
2.86 | 0.79 | 3.66 | 1.80 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates · fundamentals updated 28 Sep 2026